» Articles » PMID: 36659922

Design of Nanobody-based Bispecific Constructs by Affinity Maturation and Umbrella Sampling Simulations

Overview
Specialty Biotechnology
Date 2023 Jan 20
PMID 36659922
Authors
Affiliations
Soon will be listed here.
Abstract

Random mutagenesis is the natural opportunity for proteins to evolve and biotechnologically it has been exploited to create diversity and identify variants with improved characteristics in the mutant pools. Rational mutagenesis based on biophysical assumptions and supported by computational power has been proposed as a faster and more predictable strategy to reach the same aim. In this work we confirm that substantial improvements in terms of both affinity and stability of nanobodies can be obtained by using combinations of algorithms, even for binders with already high affinity and elevated thermal stability. Furthermore, approaches allowed the development of an optimized bispecific construct able to bind simultaneously the two clinically relevant antigens TNF-α and IL-23 and, by means of its enhanced avidity, to inhibit effectively the apoptosis of TNF-α-sensitive L929 cells. The results revealed that salt bridges, hydrogen bonds, aromatic-aromatic and cation-pi interactions had a critical role in increasing affinity. We provided a platform for the construction of high-affinity bispecific constructs based on nanobodies that can have relevant applications for the control of all those biological mechanisms in which more than a single antigen must be targeted to increase the treatment effectiveness and avoid resistance mechanisms.

Citing Articles

Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.

Liu J, Wu L, Xie A, Liu W, He Z, Wan Y J Nanobiotechnology. 2025; 23(1):87.

PMID: 39915791 PMC: 11800653. DOI: 10.1186/s12951-025-03169-5.


Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.

Medina Perez V, Baselga M, Schuhmacher A Cancers (Basel). 2024; 16(15).

PMID: 39123409 PMC: 11311928. DOI: 10.3390/cancers16152681.


A comprehensive overview of recent advances in generative models for antibodies.

Meng F, Zhou N, Hu G, Liu R, Zhang Y, Jing M Comput Struct Biotechnol J. 2024; 23:2648-2660.

PMID: 39027650 PMC: 11254834. DOI: 10.1016/j.csbj.2024.06.016.


Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors.

Martarelli N, Capurro M, Mansour G, Jahromi R, Stella A, Rossi R Int J Mol Sci. 2024; 25(13).

PMID: 39000338 PMC: 11242627. DOI: 10.3390/ijms25137231.


Structure-based computational design of antibody mimetics: challenges and perspectives.

Chaves E, Coelho D, Cruz C, Moreira E, Simoes J, Nascimento-Filho M FEBS Open Bio. 2024; 15(2):223-235.

PMID: 38925955 PMC: 11788748. DOI: 10.1002/2211-5463.13855.


References
1.
Kang G, Hu M, Ren H, Wang J, Cheng X, Li R . VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer . Cancer Biol Med. 2021; . PMC: 8330535. DOI: 10.20892/j.issn.2095-3941.2020.0568. View

2.
Sands B, Chen J, Feagan B, Penney M, Rees W, Danese S . Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study. Gastroenterology. 2017; 153(1):77-86.e6. DOI: 10.1053/j.gastro.2017.03.049. View

3.
Julian M, Li L, Garde S, Wilen R, Tessier P . Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Sci Rep. 2017; 7:45259. PMC: 5368667. DOI: 10.1038/srep45259. View

4.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

5.
Nie J, Ma X, Hu F, Miao H, Feng X, Zhang P . Designing and constructing a phage display synthesized single domain antibodies library based on camel VHHs frame for screening and identifying humanized TNF-α-specific nanobody. Biomed Pharmacother. 2021; 137:111328. DOI: 10.1016/j.biopha.2021.111328. View